HonorHealth Research Institute is one of just 30 sites worldwide participating in this first ALS prevention study, sponsored by Biogen. The focus of the study is to identify individuals who are genetically predisposed to acquiring ALS, specifically those who carry the SOD1 gene but who don’t yet show any symptoms.Continue reading→

TEMPE, Ariz., May 18, 2023 /PRNewswire/ — GT Medical Technologies, Inc. announced receipt of the 1,000^th order for GammaTile Therapy.

Driven to overcome the limitations of current treatments for brain tumors and improve the standard of care, a team of brain tumor specialists joined forces to form GT Medical Technologies, Inc. GammaTile Surgically Targeted Radiation Therapy (STaRT) is the newest option for patients undergoing brain tumor resection. Continue reading→

RESEARCHTRIANGLE PARK, N.C. and SCOTTSDALE, ARIZ. – In response to the growing and ever-changing clinical research landscape and the need to bring innovative treatments to patients faster, Worldwide Clinical Trials (Worldwide), a leading global, full-service contract research organization (CRO), has expanded its Site Alliance Collaboration with new partners across the United States and Europe.Continue reading→

This marks the third consecutive year that Castle has been recognized with a MedTech Breakthrough Award for its innovative testing solutionsContinue reading→

On May 16,  2023, advocacy took center stage on AZBioPEERS, with a discussion on how Advocacy Matters with leaders from Washington, D.C. and Arizona.  Continue reading→

In this KOL Conversation, two AZBio Board Members discuss drug development and the challenges created for health innovators by provisions in the Inflation Reduction Act. Continue reading→

Guayule is a sustainable crop with the potential to provide a reliable domestic rubber source.Continue reading→

Ivy Brain Tumor Center is Leading the Way in Brain Cancer Research and Treatment
Continue reading→